Crespo Blas Coll serves as Executive at Structure Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Crespo Blas Coll has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 18, 2025 involved selling 8,106 shares valued at $62.7K.
Crespo Blas Coll currently holds 216,807 shares of Structure Therapeutics Inc. (GPCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Crespo Blas Coll has been a net neutral trader of GPCR stock. They have purchased $0 and sold $0 worth of shares.
Crespo Blas Coll's most recent insider trade was on Sep 18, 2025, when they sold 8,106 shares at $7.74 per share.
Get notified when new Form 4 filings are submitted
| $6.84 |
| Discretionary |
| Jul 1, 2025 | GPCR | $0 | Award | 7,992 | $N/A | Discretionary |
| Mar 1, 2025 | GPCR | $9.8K | Payment | 1,233 | $7.92 | Discretionary |
| Sep 18, 2024 | GPCR | $0 | Award | 90,600 | $N/A | Discretionary |